This live session has ended. To view the recording, click the VIDEO button below.
Launching in early 2022, NEJM Evidence is a new clinical research journal from NEJM Group with fresh, bold ideas about clinical trial design. Come hear editor-in-chief Jeffrey Drazen, MD and his senior editorial team talk about why it’s so important for clinicians to evaluate how trial methods and results impact clinical decision-making.